[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$brns

Barinthus Biotherapeutics announces positive Phase X Celiac Disease trial results for VTP-1000, driving significant social media attention and engagement.

About $brns

Barinthus Biotherapeutics plc is a biopharmaceutical company focused on developing novel therapies.

Insights

Engagements: XX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
X Week: XXXXX +68%
X Month: XXXXX -XX%
X Months: XXXXXXX +671%
X Year: XXXXXXX -XX%
1-Year High: XXXXXXX on 2025-07-16
1-Year Low: X on 2025-03-08

Engagements by network (24h): X: XX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XXXX%
X Month: XX +97%
X Months: XXXXX +1,988%
X Year: XXXXX +760%
1-Year High: XXXXX on 2025-07-17
1-Year Low: X on 2025-01-01

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $brns in the last XX hours which is no change from in the previous XX hours Daily Average: XX
X Week: XX +11%
X Month: XX +73%
X Months: XXXXX +2,075%
X Year: XXXXX +1,267%
1-Year High: XXX on 2025-07-17
1-Year Low: X on 2024-12-16

The most influential creators that mention $brns in the last XX hours

Creator Rank Followers Posts Engagements
@OzmosiHealth X XXXXX X X

View More

Top $brns Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$BRNS Barinthus Biotherapeutics presented P1 Celiac Disease results on 2025-12-10 for VTP-1000 More Info:"
X Link @OzmosiHealth 2025-12-11T18:33Z 3021 followers, XXX engagements

"📌 Biotech Stock News 12/10 @ Open $TERN XX% $650M Offering $DYN X% $350M Public Offering $BRNS X% VTP-1000 Trial Update $MDWD X% Clinical Data on NexoBrid's Effectiveness $GPCR X% Pricing of $650M Offering $SGMT X% Denifanstat NDA Accepted by China NMPA $PTCT X% Health Canada Approves Sephience $ALC X% Response to Increased Acquisition Price $LXRX X% ACSL5 Preclinical Data Publucation $PFE X% TUKYSA Extends Survival 8mths $LLY X% Build $6B facility in Alabama $KYMR X% $602M Offering $AMRX X% Epinephrine Injection FDA Approval $NCNA -X% NUC-7738 Latest Data $PRAX -X% Elsunersen Accelerated"
X Link @BiopharmIQ 2025-12-10T16:32Z 28.1K followers, 1703 engagements

"ADUR has triple digit potential $ATNF $BRNS $PEW $APM $ABVE $TDTH $DJT $GME $INKT $YHC $ZEPP $CYCC $SBET $HUBC $NUWE $GAME $BRNS $DTST $SRM $HOLO $ZBAI $BMNR $BGL $BTC $ETH $SOL $XRP $ADA $BKKT $BTBT $MLGO $NVDA $SPY $DJT $GTI $VLCN $BSLK $PHOE $AI $NVDA"
X Link @mariostario2019 2025-12-04T18:18Z XX followers, XXX engagements

"$SYM $JYD $BRNS 📊 Get free access to professional-grade investment strategies and in-depth market analysis reports. 🌐 Join a global investor network to share wisdom and optimize investment decisions"
X Link @slone7777 2025-12-03T18:37Z X followers, XXX engagements